Associated Papers
Mutational profiling using liquid biopsy to guide targeted therapy in patients with metastatic cancer.
Mazouji O et al.
Scientific Reports, 2025
MMR deficiency is frequent in colorectal carcinomas with diffuse SLFN11 immunostaining: clinicopathologic and molecular study of 31 cases identified among 3,300 tumors.
Kaczorowski M et al.
The Journal of Pathology. Clinical Research, 2025
40105034 (PubMed )
Supplement: CJP2-11-e70025-s003.xlsx › Table_S2
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.
Neumayer G et al.
Nature Communications, 2024
38992003 (PubMed )
Supplement: 41467_2024_49400_MOESM8_ESM.zip › Source_Data › Supplemental_Figure_5 › Supplemental_Figure_5H › Supplemental_Figure_5H.xlsx › B10_iPSC
Germline Variants in Cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors.
Jovanović A et al.
International Journal of Molecular Sciences, 2023
Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel.
Byrjalsen A et al.
Familial Cancer, 2021
34061292 (PubMed )
Supplement: 10689_2021_254_MOESM2_ESM.xlsx › References
Identification of a novel inherited ALK variant M1199L in the WNT type of medulloblastoma.
Trubicka J et al.
Folia Neuropathologica, 2016
Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.
Coco S et al.
Journal of Human Genetics, 2012
Select a paper to view details